KDM5B predicts temozolomide-resistant subclones in glioblastoma
Vivien Ullrich(German Cancer Research Center), Björn Scheffler(German Cancer Research Center), Hanah Hadice Gull(Essen University Hospital), Barbara M. Grüner(West German Heart and Vascular Center Essen), Alexander Roesch(University of Regensburg), Tobias Blau(University of Duisburg-Essen), Sied Kebir(University of Bonn), Igor Cima(Deutsches Konsortium für Translationale Krebsforschung), Loona Meyer(German Cancer Research Center), Pia Berger(German Cancer Research Center), Kathy Keyvani(Essen University Hospital), Ulrich Sure(University of Duisburg-Essen), Madeleine Dorsch(University of Duisburg-Essen), Anna Baginska(Düsseldorf University Hospital), Laurèl Rauschenbach(University of Bonn), Sarah Langer(German Cancer Research Center), Celia Dobersalske(Düsseldorf University Hospital), Martin Glas(University of Bonn), Sarah Ertmer(German Cancer Research Center), Philip Dujardin(Düsseldorf University Hospital)
Cited by 4
Related Papers
Multipotent Stem/Progenitor Cells with Similar Properties Arise from Two Neurogenic Regions of Adult Human Brain
|Experimental Neurology|1999|523
Microglia instruct subventricular zone neurogenesis
|Glia|2006|394
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
|Genes & Development|2015|278
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
|Proceedings of the National Academy of Sciences|2011|261